SI Joint Injection Ultrasound: Accuracy vs Fluoroscopy

Ultrasound-guided sacroiliac joint injections deliver corticosteroid, anesthetic, or regenerative agents into the SI joint using real-time ultrasound imaging to steer the needle, avoiding the ionizing radiation that comes with fluoroscopy or CT guidance. The technique is feasible and increasingly common, though its accuracy at landing the needle inside the joint cavity itself remains a genuine point of debate among pain specialists. For certain patients, particularly pregnant women, the radiation-free nature of ultrasound makes it the clear first choice.

Why SI Joint Pain Is Hard to Pin Down

The sacroiliac joint sits where the base of the spine meets the pelvis, and it is one of the trickier sources of low back and buttock pain to diagnose. Part of the difficulty is anatomical. The joint receives nerve supply from multiple levels. Nerve fibers have been confirmed inside the joint capsule and surrounding ligaments, with input described from dorsal branches of L5 through S2 and sometimes from the ventral side as well.¹ More recent dissection work has shown that these nerve branches, along with accompanying blood vessels, travel through tunnels and gaps in the surrounding ligaments as neurovascular bundles, and compression or irritation of those bundles may itself generate pain.² Because of this diffuse innervation, SI joint pain can mimic hip problems, lumbar disc issues, or piriformis syndrome.

Physical examination maneuvers that are supposed to stress the SI joint and reproduce pain have not proven reliable enough to confirm the diagnosis on their own. A systematic review with meta-analysis found that clusters of these provocation tests do not provide sufficient accuracy for ruling the SI joint in as the pain source.³ An earlier study went further, concluding that neither patient-reported symptoms nor provocative maneuvers are sensitive or specific for SI joint pain when compared against the standard of a diagnostic injection block.⁴ This is exactly why injections matter twice over: they serve as both diagnostic tools, confirming the SI joint as the pain generator when the anesthetic provides temporary relief, and as therapeutic treatments when a longer-acting agent is added.

How the Ultrasound-Guided Procedure Works

The patient typically lies face down. A low-frequency curvilinear ultrasound probe is placed over the lower back and pelvis to identify bony landmarks, specifically the sacrum and the posterior iliac crest. From there, the practitioner looks for the cleft between the sacrum and the ilium, which represents the SI joint line. One well-established approach uses the posterior sacral foramina as reference points. Early cadaver and patient work demonstrated that ultrasound-guided needle insertion into the SI joint is feasible at two levels defined by the first and second posterior sacral foramina.⁵

Once the target is identified, a spinal needle is advanced under real-time imaging until it contacts bone at the joint line. Some practitioners aim for the lower pole of the joint, where the gap between sacrum and ilium tends to be widest and easier to access. Others use a superior approach depending on the clinical situation. In patients with metastatic bone tumors near the pelvis, for example, the approach can be tailored based on tumor location and the structural integrity of the joint.⁶ This flexibility is one of the practical strengths of ultrasound: the practitioner can see soft tissue structures in real time and adjust on the fly.

Accuracy Compared to Fluoroscopy

Here is where the evidence gets complicated and, frankly, a bit humbling for ultrasound advocates. Fluoroscopy, which uses live X-ray imaging, has long been the traditional guidance method. It lets the practitioner inject contrast dye and watch it spread inside the joint on screen, providing direct visual confirmation that the needle tip is intra-articular. Ultrasound cannot do that. It shows the needle path and the bony surface, but it cannot confirm that injected medication has actually entered the joint space rather than pooling in the surrounding ligaments.

A prospective randomized study comparing the two approaches found that ultrasound-guided injections landed inside the joint about 87% of the time, while fluoroscopy-guided injections achieved roughly 98% accuracy.⁷ That gap matters less than it might seem at first glance, because even fluoroscopy is not infallible, but it does represent a meaningful difference in needle placement precision.

A cadaver study painted a starker picture for ultrasound. When researchers injected latex dye under ultrasound guidance and then checked where it ended up, only 1 out of 20 injections was truly intra-articular. Most of the dye spread into the interosseous ligament rather than the joint cavity. Fluoroscopy confirmed intra-articular placement in half of its attempts in the same study, and the researchers described fluoroscopy as clearly having a higher success rate for getting into the joint space proper.⁸ The difference between the two studies likely reflects methodology: the cadaver study used a more stringent definition of “intra-articular” and involved dissection to verify dye location, while the clinical study relied on fluoroscopic confirmation after the ultrasound-guided injection.

These accuracy numbers raise an important question: does it actually matter whether the injectate lands inside the joint cavity versus the surrounding ligaments? Given that pain-generating nerve fibers run through those very ligaments, some researchers argue that a peri-articular injection may relieve pain just as well as a perfectly intra-articular one. That possibility would explain why clinical outcomes between the two techniques often look similar despite the accuracy gap.

Do Clinical Outcomes Actually Differ?

A systematic review examining ultrasound- versus fluoroscopy-guided injections across the lower back found no difference in pain relief, procedure time, number of needle passes, changes in disability scores, complication rates, post-procedure opioid use, or patient satisfaction.⁹ A direct head-to-head comparison of the two approaches for SI joint injection in patients with chronic low back pain similarly found no significant differences in physical functioning, discomfort during the procedure, opioid use, or patient satisfaction.¹⁰

So ultrasound may place the needle slightly less precisely, but patients do not seem to notice the difference in terms of pain relief. This is a recurring theme in interventional pain medicine: anatomical precision and functional outcomes do not always track as tightly as you’d expect.

What the Injections Actually Achieve

A retrospective study of 75 patients receiving ultrasound-guided SI joint injections found that about 57% achieved at least a 50% reduction in pain after the first injection, measured at 48 hours. At one week, roughly 55% still held that level of relief. By three months, only about 35% maintained it.¹¹ The median time before patients came back for another injection was about 21 months, suggesting that even when the initial relief fades somewhat, many patients get a reasonably durable window of improvement.

Those numbers reflect the reality that SI joint injections, like most joint injections, are not permanent fixes. They buy time, reduce inflammation, and sometimes help clarify the diagnosis. For some patients, one injection is enough to break a pain cycle and allow physical therapy to take hold. For others, repeat injections become part of an ongoing management strategy.

What Gets Injected

The standard cocktail is a corticosteroid mixed with a local anesthetic. The anesthetic provides immediate but temporary relief (useful for confirming the diagnosis), while the steroid reduces inflammation over days to weeks. But corticosteroid effects tend to wear off, and repeated steroid injections carry their own risks over time, including cartilage damage and tendon weakening.

This has driven interest in platelet-rich plasma as an alternative. A randomized study comparing PRP to steroid for ultrasound-guided SI joint injection found that pain intensity was significantly lower in the PRP group at six weeks and three months. By three months, only about a quarter of steroid patients still had meaningful relief, compared to 90% of PRP patients.¹² A separate randomized study comparing autologous platelet-rich fibrin (a close cousin of PRP) to steroid found that the platelet-derived group showed significantly greater improvement at every follow-up point from one week through six months.¹³

A study looking at PRP injections specifically for SI joint dysfunction found significant reductions in disability and pain scores at six months, though the improvement tended to plateau after about four weeks, with no further statistically significant gains between four weeks and three months or between three and six months.¹⁴ The overall picture for PRP is promising but still based on relatively small studies. Larger trials are needed before PRP becomes a standard recommendation over steroids.

The Safety Case for Ultrasound

The most straightforward advantage of ultrasound over fluoroscopy is the absence of ionizing radiation. Fluoroscopy exposes both the patient and the clinical team to X-rays, and while the dose per procedure is small, it accumulates for practitioners performing dozens of procedures a week over a career. Ultrasound also allows visualization of soft tissue structures that fluoroscopy simply cannot see, including nearby blood vessels, nerves, and muscles. And it can be done at the bedside without a dedicated fluoroscopy suite.¹⁵

That bedside capability matters more than it might sound. Fluoroscopy requires a specially equipped procedure room, scheduling, and sometimes facility fees. Ultrasound is portable. A clinician with a machine in their office can perform the injection during a regular visit, cutting wait times and overhead. For patients who live far from a pain management center or who need repeated injections, this convenience is practical and meaningful.

Pregnancy and Postpartum SI Joint Pain

Pregnancy-related SI joint pain is common. Hormonal changes loosen pelvic ligaments, the growing uterus shifts the center of gravity, and the weight gain puts increased stress on the SI joints. When conservative treatment like physical therapy and support belts fails, an injection may be warranted. But fluoroscopy is off the table because of fetal radiation exposure, and CT guidance is even worse in this regard.

Ultrasound fills this gap perfectly. A case series of pregnant and postpartum women with pelvic girdle pain found ultrasound to be an effective and safe imaging method for SI joint injection, calling it an excellent alternative to fluoroscopy in this population.¹⁶ A systematic review of the literature on acute inflammatory sacroiliitis in pregnant and postpartum women reached the same conclusion, finding ultrasound-guided injections to be both safe and effective in this context.¹⁷ For these patients, ultrasound is not just an alternative to fluoroscopy — it is the only reasonable image-guided option.

Limitations and When Ultrasound Struggles

Ultrasound’s biggest weakness for SI joint work is body habitus. The SI joint sits deep within the pelvis, covered by thick layers of muscle and, in many patients, adipose tissue. In people with a higher BMI, the bony landmarks become harder to see, the needle has to travel farther, and the image quality degrades. This is a recognized challenge that can make the procedure significantly more difficult or even impractical in some cases.

Procedure time can also be longer. One study comparing the two methods reported that fluoroscopy-guided injections took an average of about 7 minutes, while ultrasound-guided injections averaged about 9.3 minutes, roughly 26% longer.¹⁸ A few extra minutes per procedure may not sound like much, but it adds up in a busy clinic and reflects the additional cognitive load of interpreting ultrasound anatomy in real time. The systematic review mentioned earlier found no overall difference in procedure time across lower-back injections broadly, so this may vary depending on practitioner experience.¹⁹

Operator skill matters enormously. Ultrasound-guided injection is more operator-dependent than fluoroscopy. A practitioner who performs these regularly will get better images, faster needle placement, and higher accuracy than someone who does it occasionally. This is one area where training and volume genuinely predict results.

Beyond the Joint Itself: Ultrasound-Guided Lateral Branch Blocks

When SI joint injections provide temporary relief but the pain keeps returning, some patients become candidates for radiofrequency ablation of the sacral lateral branches, the small nerves that carry pain signals from the joint. Before ablation, diagnostic blocks of these nerves are performed to confirm they are the right targets. These blocks can also be done under ultrasound guidance.

A randomized controlled trial of 40 patients compared fluoroscopy- and ultrasound-guided sacral lateral branch blocks. The ultrasound approach was associated with shorter procedure times, fewer needle passes, and a lower rate of accidentally puncturing a blood vessel. The pain-relief effect of the blocks, however, was equivalent between the two methods, with no statistical difference in the proportion of patients achieving complete pain relief at each nerve target.²⁰ The lower rate of vascular breach is worth highlighting: accidentally injecting anesthetic into a blood vessel near the sacrum can cause transient but unpleasant symptoms, and ultrasound’s ability to visualize vessels in real time helps avoid this.

Fusion Imaging and What Comes Next

One approach to closing the accuracy gap between ultrasound and fluoroscopy is fusion imaging, where previously obtained CT or MRI scans are overlaid onto the live ultrasound feed in real time. This gives the practitioner the soft-tissue visualization and radiation-free benefits of ultrasound combined with the precise bony anatomy detail of CT or MRI. An early proof-of-concept study demonstrated that fusing real-time ultrasound with CT images to guide needle insertion into the SI joint is feasible both in lab models and in living patients.²¹ More recently, MRI/ultrasound fusion has been used successfully for SI joint corticosteroid injections in patients with axial spondyloarthritis.²²

Fusion imaging is not yet widely available outside academic centers, and it adds a layer of complexity and cost that may not be justified for straightforward cases. But for patients with unusual anatomy, prior surgery, or joints that are difficult to image with ultrasound alone, it represents a genuinely useful tool. As the software improves and becomes more integrated into standard ultrasound machines, it may eventually shift the accuracy calculus enough to make ultrasound guidance comparable to fluoroscopy even by the strictest definitions of intra-articular placement.

Choosing Between Guidance Methods

There is no single right answer for every patient. Fluoroscopy remains the more precise technique for confirming intra-articular needle placement and is the better choice when the injection must be definitively inside the joint, such as for a high-stakes diagnostic block that will determine whether a patient proceeds to surgery or ablation. Ultrasound makes more sense when radiation avoidance is a priority (pregnancy, pediatric patients, practitioners performing high volumes of procedures), when the clinical setting does not have fluoroscopy available, or when the goal is peri-articular delivery to the surrounding ligaments and soft tissues. The two methods produce equivalent pain relief and patient satisfaction in most head-to-head comparisons, so the choice often comes down to clinical context, practitioner expertise, and available equipment rather than a clear superiority of one over the other.